Jaeckel Rhett, Thieme Matthias, Czeslick Elke, Sablotzki Armin
Klinikum "St Georg" gGmbH, Department of Anaesthesiology and Intensive Care Medicine, Delitzscher Str, 04129 Leipzig, Germany.
J Med Case Rep. 2010 Mar 5;4:82. doi: 10.1186/1752-1947-4-82.
Homozygous sickle cell carriers have an increased perioperative mortality. Some indications may justify an exchange blood transfusion to reduce the proportion of haemoglobin S. The advantages of general blood transfusion in a perioperative setting have not been proven and thus remain controversial. It is not clear whether reducing the proportion of haemoglobin S minimizes perioperative complications or whether patients with sickle cell disease in a stable clinical condition benefit from an exchange blood transfusion in a perioperative setting.
We report the case of two Angolan children aged 10 and 11 respectively, of African origin with sickle cell anaemia who underwent surgery to treat chronic necrosis, fistula of the bones and bone destruction. This presentation describes the perioperative course, including general anaesthesia. A partial exchange blood transfusion decreased S-haemoglobin levels from 81% to 21% and simultaneously treated the anaemia.
There is a consensus that imbalances in homoeostasis, including operative procedures, can cause a critical exacerbation of sickle cell disease. The case presented here illustrates a strategy for successfully managing sickle cell disease in the perioperative period to minimize its complications. It is important for the anaesthesiologist to carefully manage pulmonary gas exchange and to ensure sufficient tissue perfusion, balanced fluid resuscitation and normothermia, while keeping in mind the level of organ impairment in order to prevent an acute exacerbation of sickle cell disease.We performed a partial exchange blood transfusion due to the following factors: high haemoglobin S-fraction, anaemia, operating procedure at several sites, and difficult management of body temperature. Esmarch ischemia is an established tool for preventing uncontrolled blood loss. There is no known contraindication for this, but attention must be paid to prevent uncontrolled tissue ischemia and acidosis. The use of regional anaesthesia should be considered for postoperative pain management.
纯合子镰状细胞携带者围手术期死亡率增加。某些指征可能使换血疗法合理,以降低血红蛋白S的比例。围手术期进行常规输血的优势尚未得到证实,因此仍存在争议。目前尚不清楚降低血红蛋白S的比例是否能将围手术期并发症降至最低,也不清楚临床病情稳定的镰状细胞病患者在围手术期进行换血疗法是否有益。
我们报告了两名分别为10岁和11岁的安哥拉儿童的病例,他们是非洲裔镰状细胞贫血患者,接受了治疗慢性坏死、骨瘘和骨质破坏的手术。本报告描述了围手术期过程,包括全身麻醉。部分换血疗法将血红蛋白S水平从81%降至21%,同时治疗了贫血。
人们一致认为,包括手术操作在内的内环境稳态失衡可导致镰状细胞病严重恶化。此处呈现的病例说明了在围手术期成功管理镰状细胞病以将其并发症降至最低的策略。麻醉医生仔细管理肺气体交换并确保充足的组织灌注、平衡的液体复苏和正常体温非常重要,同时要牢记器官损害程度以防止镰状细胞病急性加重。由于以下因素我们进行了部分换血疗法:血红蛋白S比例高、贫血、多处手术操作以及体温管理困难。埃斯马赫缺血法是预防失控性失血的既定方法。对此尚无已知禁忌证,但必须注意防止失控性组织缺血和酸中毒。术后疼痛管理应考虑使用区域麻醉。